Change of 65.71% for VIVOS INC (OTCMKTS:RDGL)’s shares shorted was registered. FINRA published in April RDGL’s total 12,000 shares shorted. The 35,000 previous shares are down with 65.71%.

The stock decreased 6.21% or $0.0002 during the last trading session, reaching $0.0031.Vivos Inc. has volume of 328,006 shares. Since April 18, 2018 RDGL has 0.00% and is . The stock underperformed the S&P 500 by 4.37%.

Vivos Inc., a radiation oncology focused medical device company, develops brachytherapy devices for the treatment of non-resectable tumors.The company has $4.24 million market cap. The company's brachytherapy products include yttrium-90 RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals.Currently it has negative earnings. It serves government and commercial clients in the medical and veterinary sectors.

Another two news for Vivos Inc. (OTCMKTS:RDGL) were recently posted by: Seekingalpha.com on September 24, 2018 with title “Vivos to halt the toxic selling and eliminate the secured toxic debt – Seeking Alpha”. The other Seekingalpha.com‘s article was titled “Vivos Inc successfully treats canine sarcoma with IsoPet – Seeking Alpha” and posted on May 31, 2018.